Bioconjugate companies develop technologies that chemically link biological molecules to drugs, imaging agents, polymers or other functional components. These approaches are used to improve targeting, stability, delivery and detection across therapeutics, diagnostics and life science research.
This category includes companies working on:
Browse 33 UK bioconjugate companies below.
Data-driven cis-bispecific antibody-drug conjugates for solid tumour cancers
Promatix Biosciences is an oncology drug discovery company developing next-generation bispecific antibody-drug conjugates through data-driven target pairing. Using a proteomics…
ADC pipeline targeting mutant stem cells in blood cancers
Alethio Therapeutics Limited is a preclinical-stage biotechnology company developing antibody-drug conjugates for myeloproliferative neoplasms, a group of chronic blood cancers.…
Bispecific antibody-drug conjugates for cancer-selective precision therapy
BiVictriX Therapeutics is a clinical-stage biotechnology company developing bispecific antibody-drug conjugates for cancer. The platform targets pairs of cancer-specific antigens…
Sterile injectable drug product development and fill-finish manufacturing
Curia is a global contract development and manufacturing organisation operating from the West of Scotland Science Park in Glasgow. The facility specialises in sterile injectable…
Carbon nanodot delivery platform for RNA-based crop protection
CDotBio Limited is a biotech developing carbon nanodot technology to improve the delivery and stability of RNA-based biopesticides and other crop inputs. The platform uses…
Novel ADC payloads targeting NMT enzymes in cancer
Myricx Bio is a clinical-stage biotechnology company developing a novel class of antibody-drug conjugate payloads based on inhibition of N-myristoyltransferase, an enzyme…
Sustainable conjugation technology for antibody-drug conjugate manufacturing
Vitamab is a Manchester-based biotechnology company developing conjugation technology to strengthen the antibody-drug conjugate manufacturing supply chain. Its proprietary system…
Contract development and manufacturing of complex small molecule APIs and ADCs
Sterling Pharma Solutions is a contract development and manufacturing organisation specialising in complex small molecule active pharmaceutical ingredient development and cGMP…
Next-generation ADC linker chemistry for precision cancer therapeutics
Siftr Bio is a biotechnology company developing novel linker chemistry for antibody-drug conjugates. Current ADC linkers have limited diversity and insufficient selectivity,…